Real-world data insights

Better understand disease, provide deeper insights into the diagnostic pathway, and accelerate therapy development

Real-world data insights

Better understand disease, provide deeper insights into the diagnostic pathway, and accelerate therapy development

Disease insights

With over 1 million patients tested, we can provide insights into observed prevalence rates and can inform future therapy development

Informed targeting

By identifying where testing is taking place, our sponsors can improve allocation of clinical trial sites or commercial resources

Value-add for clients

Sponsors can better partner with health systems and major centers by sharing insights on genetic testing trends, treatment patterns, and more

Custom analysis allows for deeper understanding of correlations between phenotype and genotype and the spectrum of clinical presentations

Promotions can be targeted to certain clinicians, centers, or geographical areas

Published program research can be used to develop custom CME or educational programs for clinicians

Interested in partnering for research opportunities?

Our high-quality, next-generation sequencing (NGS)-based diagnostic testing offers research opportunities using whole exome or whole genome sequencing. To learn more, email us at partners@invitae.com.

Patient privacy

Invitae takes patient privacy very seriously and will never share personal, identifiable information with the sponsor unless a patient specifically authorizes us to do so. For more information on how we protect privacy, please visit our privacy page.